North America Typhoid Fever Vaccines Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine and Others) and Route of administration (Oral and Injectable) and Country
Market Introduction
Typhoid is an infectious disease caused by Salmonella Typhi, through ingestion of contaminated food and water. This intense illness is identified by prolonged fever, headache and nausea, loss of appetite and constipation or sometimes diarrhea. Increasing threats of typhoid and growing threats of drug resistance has helped typhoid vaccines to boost its market especially among rural and hard-to-reach communities where progress in medical services, infrastructure and development may be slow.
Get more information on this report :
Market Overview and Dynamics
The North America typhoid fever vaccines market is expected to reach US$ US$ 182.71 million in 2027 from US$ 89.84 million in 2019. The market is estimated to grow with a CAGR of 9.6% from 2020-2027. Factors such as increase in number of Americans travelling to developing countries for business and leisure is the key factor contributing to the growth of the market. On the other hand, the market is likely to have negative impact due to risk of associated with typhoid fever vaccines.
Key Market Segments
On the basis of vaccine type, the typhoid fever vaccines market has been segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR in the market during the forecast period. Global typhoid fever vaccines market based on route of administration is segmented into oral and injectable. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR in the market during the forecast period
Major Sources and Companies Listed
Some of the major secondary sources for North America typhoid fever vaccines market included in the report are, National Travel & Tourism Office, Conference Board of Canada (CBoC), International Trade Administration, World Health Organization and others.
Reasons to buy the report
- To understand the North America typhoid fever vaccines market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America typhoid fever vaccines market
- Efficiently plan M&A and partnership deals in North America typhoid fever vaccines market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America typhoid fever vaccines market
- Obtain market revenue forecast for market by various segments from 2019-2027 in North America.
North America Typhoid Fever Vaccines Market –
By Vaccine Type
- Live Attenuated Vaccine
- Capsular Polysaccharide Vaccines
- Conjugate Vaccine
- Others
By Route of Administration
- Oral
- Injectable
- US
- Canada
- Mexico
Company Profiles
- Sanofi
- GlaxoSmithKline plc
- Paxvax Inc
- Prokarium Ltd
- Scandinavian Biopharma
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Typhoid Fever Vaccines Market – By Vaccine Type
1.3.2 North America Typhoid Fever Vaccines Market – By Route of Administration
1.3.3 North America Typhoid Fever Vaccines Market – By Country
2. North America Typhoid Fever Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Typhoid Fever Vaccines Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America Typhoid Fever Vaccines Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Typhoid Fever Vaccines Market Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increase in Number of Americans Travelling Outside North America
5.2 Key Restraints
5.2.1 Risks Associated with Typhoid Fever Vaccines
5.3 Key Market Opportunities
5.3.1 Increasing Pharmaceutical and Biopharmaceutical Industry
5.4 Future Trend
5.4.1 Initiatives to Reduce Typhoid Burden
5.5 Impact Analysis
6. Typhoid Fever Vaccines Market – North America Analysis
6.1 North America Typhoid Fever Vaccines Market Revenue Forecasts and Analysis
7. Typhoid Fever Vaccines Market – By Vaccine Type
7.1 Overview
7.2 Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
7.3 Live Attenuated Vaccine
7.3.1 Overview
7.3.2 Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Capsular Polysaccharide Vaccines
7.5.1 Overview
7.5.2 Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Conjugate Vaccine
7.6.1 Overview
7.6.2 Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
8. Typhoid Fever Vaccines Market Analysis – By Route of Administration
8.1 Overview
8.2 Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
8.2.1 Oral
8.2.1.1 Overview
8.2.2 Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Injectable
8.3.1 Overview
8.3.2 Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9. Typhoid Fever Vaccines Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 North America: Typhoid Fever Vaccines Market
9.1.1 Overview
9.1.2 North America: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.4 North America: Typhoid Fever Vaccines Market, by Route of Administration, 2018–2027 (USD Million)
9.1.5 North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
9.1.6 US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.6.3 US: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.1.7 Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.7.3 Canada: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.1.8 Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.8.3 Mexico: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Paxvax Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 PT Bio Farma
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 BIO-MED
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Sanofi
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 GlaxoSmithKline plc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 3. US Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 4. US Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 9. Glossary of Terms, North America Typhoid Fever Vaccines Market
LIST OF FIGURES
Figure 1. Typhoid Fever Vaccines Market Segmentation
Figure 2. North America Typhoid Fever Vaccines Market Overview
Figure 3. Convex Segment Held Largest Share of Typhoid Fever Vaccines Market
Figure 4. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Typhoid Fever Vaccines Market- Leading Country Markets (US$ Mn)
Figure 7. North America : PEST Analysis
Figure 8. Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraints
Figure 9. North America Typhoid Fever Vaccines Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 10. Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
Figure 11. Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 16. Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. North America: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 19. North America Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 20. North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
Figure 21. US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 22. Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in North American Countries
- Sanofi
- GlaxoSmithKline plc
- Paxvax Inc
- Prokarium Ltd
- Scandinavian Biopharma
- To understand the North America typhoid fever vaccines market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America typhoid fever vaccines market
- Efficiently plan M&A and partnership deals in North America typhoid fever vaccines market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America typhoid fever vaccines market
- Obtain market revenue forecast for market by various segments from 2019-2027 in North America.